title: Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state.
abstract: The tolerogenic nature of the liver allows daily exposure to gut-derived foreign Ags without causing inflammation, but it may facilitate persistent infection in the liver. NK cells play a central role in innate immunity, as well as in shaping the adaptive immune response. We hypothesized that the naive mouse liver maintains intrahepatic NK cells in a functionally hyporesponsive state. Compared with splenic NK cells, liver NK cells displayed a dampened IFN-gamma response to IL-12/IL-18 stimulation. Importantly, the liver contains a significant population of functionally hyporesponsive NK cells that express high levels of the inhibitory receptor NKG2A and lack expression of MHC class I-binding Ly49 receptors. Adoptively transferred splenic NK cells that migrate to the liver displayed phenotypic and functional changes, suggesting that the liver environment modifies NK cell receptor expression and functional responsiveness. Notably, IL-10 is present at high levels within the liver, and in vivo blockade of IL-10R resulted in a decreased percentage of intrahepatic NKG2A(+)Ly49(-) NK cells. These data suggest that the liver environment regulates NK cell receptor expression and that IL-10 contributes to the regulation of liver NK cells, in part, by maintaining a greater percentage of the hyporesponsive NKG2A(+)Ly49(-) NK cells in the liver.
authors.affiliation: Beirne B. Carter Center for Immunology Research, Department ofMicrobiology, University of Virginia, Charlottesville, VA 22908, USA.
authors.forename: Matthew G
authors.initials: MG
authors.lastname: Lassen
authors.forename: John R
authors.initials: JR
authors.lastname: Lukens
authors.forename: Joseph S
authors.initials: JS
authors.lastname: Dolina
authors.forename: Michael G
authors.initials: MG
authors.lastname: Brown
authors.forename: Young S
authors.initials: YS
authors.lastname: Hahn
mesh_terms: D019264:Adoptive Transfer; D000818:Animals; D002465:Cell Movement; D054405:Chemokine CCL3 / Q000172:deficiency / Q000235:genetics; D003602:Cytotoxicity, Immunologic; D005260:Female; D005434:Flow Cytometry; D053804:Granzymes / Q000378:metabolism; D007371:Interferon-gamma / Q000378:metabolism; D016753:Interleukin-10 / Q000378:metabolism*; D018664:Interleukin-12 / Q000494:pharmacology; D020382:Interleukin-18 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D008099:Liver / Q000276:immunology / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D055650:NK Cell Lectin-Like Receptor Subfamily A / Q000378:metabolism*; D055654:NK Cell Lectin-Like Receptor Subfamily C / Q000378:metabolism*; D053701:Receptors, Interleukin-10 / Q000276:immunology / Q000378:metabolism; D013154:Spleen / Q000276:immunology / Q000378:metabolism
chemical_list: D054405:Chemokine CCL3; D020382:Interleukin-18; D055650:NK Cell Lectin-Like Receptor Subfamily A; D055654:NK Cell Lectin-Like Receptor Subfamily C; D053701:Receptors, Interleukin-10; D016753:Interleukin-10; D018664:Interleukin-12; D007371:Interferon-gamma; D053804:Granzymes